Lanlan Xiao

438 total citations
22 papers, 256 citations indexed

About

Lanlan Xiao is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lanlan Xiao has authored 22 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 11 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Lanlan Xiao's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (7 papers) and Hepatitis B Virus Studies (5 papers). Lanlan Xiao is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (7 papers) and Hepatitis B Virus Studies (5 papers). Lanlan Xiao collaborates with scholars based in China and United States. Lanlan Xiao's co-authors include Lanjuan Li, Xiaoxin Wu, Lingjian Zhang, Xiaowei Xu, Yalei Zhao, Zhongyang Xie, Fen Zhang, Xiaoxi Ouyang, Min Wang and Danhua Zhu and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Advanced Science.

In The Last Decade

Lanlan Xiao

21 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanlan Xiao China 10 131 84 65 43 43 22 256
Laura Weichselbaum Belgium 7 139 1.1× 98 1.2× 52 0.8× 21 0.5× 34 0.8× 11 265
Agata Michalak Poland 12 128 1.0× 66 0.8× 47 0.7× 17 0.4× 30 0.7× 26 284
Xiang‐An Zhao China 10 152 1.2× 114 1.4× 55 0.8× 19 0.4× 111 2.6× 17 322
Carl Janssen Belgium 6 140 1.1× 82 1.0× 56 0.9× 14 0.3× 62 1.4× 7 255
Yunjie Dan China 11 185 1.4× 183 2.2× 45 0.7× 15 0.3× 41 1.0× 18 339
Shumei Lin China 14 308 2.4× 270 3.2× 86 1.3× 32 0.7× 73 1.7× 39 506
Gangde Zhao China 12 267 2.0× 211 2.5× 34 0.5× 60 1.4× 63 1.5× 28 363
Sally Zhao United States 4 137 1.0× 116 1.4× 35 0.5× 23 0.5× 18 0.4× 9 289
Zuyuan Lin China 10 96 0.7× 96 1.1× 129 2.0× 14 0.3× 49 1.1× 29 326
Yihui Rong China 13 168 1.3× 147 1.8× 139 2.1× 29 0.7× 97 2.3× 36 465

Countries citing papers authored by Lanlan Xiao

Since Specialization
Citations

This map shows the geographic impact of Lanlan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Xiao more than expected).

Fields of papers citing papers by Lanlan Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Xiao. The network helps show where Lanlan Xiao may publish in the future.

Co-authorship network of co-authors of Lanlan Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Xiao. A scholar is included among the top collaborators of Lanlan Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Xiao. Lanlan Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Xiang, et al.. (2025). Dynamics of a long flexible filament conveyed in the near field of a turbulent jet. Journal of Fluids and Structures. 133. 104261–104261. 1 indexed citations
3.
Zhao, Shuai, Qiuhong Liu, Fen Zhang, et al.. (2024). Longitudinal dynamic single-cell mass cytometry analysis of peripheral blood mononuclear cells in COVID-19 patients within 6 months after viral RNA clearance. BMC Infectious Diseases. 24(1). 567–567. 1 indexed citations
4.
Zhu, Huihui, Qiuhong Liu, Lingjian Zhang, et al.. (2024). CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis. Journal of Experimental & Clinical Cancer Research. 43(1). 245–245. 11 indexed citations
5.
Zhang, Fen, Lanlan Xiao, Yalei Zhao, et al.. (2023). Human menstrual blood-derived stem cells alleviate autoimmune hepatitis via JNK/MAPK signaling pathway in vivo and in vitro. Frontiers of Medicine. 17(3). 534–548. 3 indexed citations
6.
Zhang, Junlei, Lingjian Zhang, Yalei Zhao, et al.. (2023). Knockdown of CXCL1 improves ACLF by reducing neutrophil recruitment to attenuate ROS production and hepatocyte apoptosis. Hepatology Communications. 7(10). 13 indexed citations
7.
Su, Wei, Shuai Zhao, Yuqing Zhou, et al.. (2022). Tripartite motif-containing protein 46 accelerates influenza A H7N9 virus infection by promoting K48-linked ubiquitination of TBK1. Virology Journal. 19(1). 176–176. 7 indexed citations
8.
Zhang, Lingjian, Yalei Zhao, Zhongyang Xie, et al.. (2022). 1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure. Journal of Clinical and Translational Hepatology. 10(4). 651–659. 2 indexed citations
9.
Zhang, Fen, Linxiao Fan, Qiuhong Liu, et al.. (2022). Comprehensive immune cell analysis of human menstrual-blood-derived stem cells therapy to concanavalin A hepatitis. Frontiers in Immunology. 13. 974387–974387. 7 indexed citations
10.
Wu, Xiaoxin, Xiaoyun Ma, Lingjian Zhang, et al.. (2022). Immune Enhancement by the Tetra-Peptide Hydrogel as a Promising Adjuvant for an H7N9 Vaccine against Highly Pathogenic H7N9 Virus. Vaccines. 10(1). 130–130. 11 indexed citations
11.
Chen, Yanfei, Lanlan Xiao, Xuan Zhang, et al.. (2022). Gut microbiota in systemic lupus erythematosus: A fuse and a solution. Journal of Autoimmunity. 132. 102867–102867. 33 indexed citations
12.
Xiao, Lanlan, Xiaoxin Wu, Jiajia Chen, et al.. (2021). Progress in hepatitis B virus-related acute-on-chronic liver failure treatment in China: A large, multicenter, retrospective cohort study using a propensity score matching analysis. Hepatobiliary & pancreatic diseases international. 20(6). 535–541. 15 indexed citations
13.
Wu, Xiaoxin, Shu-Hao Yao, Yuqin Zhou, et al.. (2021). The viral distribution and pathological characteristics of BALB/c mice infected with highly pathogenic Influenza H7N9 virus. Virology Journal. 18(1). 237–237. 6 indexed citations
14.
Xiao, Lanlan, Lingjian Zhang, Shanshan Ma, et al.. (2021). Serum CXCL1 Is a Prognostic Factor for Patients With Hepatitis B Virus–Related Acute-On-Chronic Liver Failure. Frontiers in Medicine. 8. 657076–657076. 9 indexed citations
15.
Wu, Xiaoxin, Lanlan Xiao, & Lanjuan Li. (2020). Research progress on human infection with avian influenza H7N9. Frontiers of Medicine. 14(1). 8–20. 29 indexed citations
16.
Xiao, Lanlan, Fen Zhang, Yalei Zhao, et al.. (2020). Using advanced oxidation protein products and ischaemia-modified albumin to monitor oxidative stress levels in patients with drug-induced liver injury. Scientific Reports. 10(1). 18128–18128. 27 indexed citations
17.
Xiao, Lanlan, Xiaoxin Wu, Fen Zhang, et al.. (2020). Changes of inflammatory cytokines/chemokines during ravidasvir plus ritonavir‐boosted danoprevir and ribavirin therapy for patients with genotype 1b hepatitis C infection. Journal of Medical Virology. 92(12). 3516–3524. 2 indexed citations
18.
Ji, Feiyang, Zhongyang Xie, Daxian Wu, et al.. (2019). Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis. Scientific Reports. 9(1). 16462–16462. 26 indexed citations
19.
Wu, Xiaoxin, Keda Chen, Da‐Zhi Chen, et al.. (2019). Process optimization for the rapid production of Enterovirus 71. Cytotechnology. 71(6). 1053–1061. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Weichselbaum Breakdown of academic impact, for papers by Agata Michalak Breakdown of academic impact, for papers by Xiang‐An Zhao Breakdown of academic impact, for papers by Carl Janssen Breakdown of academic impact, for papers by Yunjie Dan Breakdown of academic impact, for papers by Shumei Lin Breakdown of academic impact, for papers by Gangde Zhao Breakdown of academic impact, for papers by Sally Zhao Breakdown of academic impact, for papers by Zuyuan Lin Breakdown of academic impact, for papers by Yihui Rong
Rankless by CCL
2026